MARKED DECREASE EXPRESSION OF E AND c ANTIGEN DURING EXACERBATION OF MYELODYSPLASTIC SYNDROME
Hiromi Namba, Koki Fujiwara, Tsuyosi Kaneko et al. · Japanese Journal of Transfusion and Cell Therapy · 2013
我々は,骨髄異形成症候群(myelodysplastic syndrome:MDS)の増悪時にE抗原及びc抗原が著しく減弱し,抗E及び抗c自己抗体検出時の直接抗グロブリン試験(DAT)が陰性になる症例を経験した. 79歳女性.2010年3月に汎血球減少症の精査・加療目的で入院となった.骨髄所見は異形成を伴った赤芽球が優位でMDS(RAEB-1)と診断された.初診時の血液型はB型RhD陽性,不規則抗体は間接抗グロブリン法(IAT)陰性であった.初診時より55病日にIATが陽性となり抗Eを検出したが,DATは陰性であった.同時に実施したRhフェノタイプ検査ではE抗原が(w+mf),c抗原が(w+mf)と極めて弱い反応を示していた.その後,抗cも検出された.骨髄細胞を用いたG-banding法の結果,種々の染色体異常を認めたが第1染色体短腕に異常は認められなかった.また,PCR-SSP法を用いたRHCE遺伝子解析の結果,55病日の検体においてC,c,E,eの増幅が認められ,R1R2(CcDEe)と判定された. 本症例はMDSの増悪に伴ってE抗原およびc抗原に著しい減弱が認められた.
Cited by 0 works. doi:10.3925/jjtc.59.813 Open-access PDF
Authors
- Hiromi Namba
- Koki Fujiwara
- Tsuyosi Kaneko
- Hitomi Nagatomo
- Haruka Kanii
- Hidetoshi Kasai
- Kazuko Osone
- 前島 理恵子
- Hidekazu Tomiyama
- Nobuhiro Wakimoto
- Naoki Shirafuji
References
- RHD/CE typing by polymerase chain reaction using sequence‐specific primers
- Loss of red cell A, B, and H antigens is frequent in myeloid malignancies
- A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies
- DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients
- Loss of Rh antigen associated with acquired Rh antibodies and a chromosome translocation in a patient with myeloid metaplasia
- Mosaicism due to myeloid lineage–restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting
- Increased detection of clinically significant antibodies and decreased incidence of delayed haemolytic transfusion reaction with the indirect antiglobulin test potentiated by polyethylene glycol compared to albumin: a Japanese study.
- Loss of D and C expression in chronic myelomonocytic leukemia
- Two cases of mosaic RhD blood-group phenotypes and paternal isodisomy for chromosome 1
- RHD deletion in a patient with chronic myeloid leukemia